Month: January 2026

Imagine completing 250 minutes of cardio a week and knowing it drops a woman’s heart disease risk by 30%—but for men, that same benefit takes over 500 minutes. Science reveals a surprising gap in how much heart-protective exercise men really need, with important implications not just for longevity, but for prostate health too. keep reading

AI in medicine is advancing rapidly, but who decides if it truly improves care? JAMA’s summit report calls attention to the urgent need for better standards, smarter oversight, and genuine collaboration so that AI benefits aren’t just promised—they’re proven. keep reading

The Sperling Prostate Center combines advanced 3T mpMRI technology with artificial intelligence for unmatched accuracy in diagnosing prostate cancer. Dr. Dan Sperling and his team use these tools to determine who truly needs a biopsy and who can safely avoid it, helping men receive highly personalized and effective care. keep reading

NAD+ precursor supplements promise anti-aging benefits, yet their effects on prostate cancer may be more complex than expected. While boosting NAD+ can support cellular wellness, research suggests it might also help cancer cells thrive. Get balanced insights from recent studies. keep reading

What if curing cancer meant strengthening your own immune defenses instead of relying on chemotherapy? With Anktiva, Dr. Patrick Soon-Shiong aims to arm the body’s natural killer cells in the fight against cancer, recently achieving FDA approval for bladder cancer and eyeing possibilities for prostate cancer and beyond. keep reading

Despite recent headlines, ibuprofen isn’t a proven shield against prostate cancer. While anti-inflammatory drugs have sparked scientific curiosity, current studies remain inconclusive on whether these over-the-counter meds actually lower prostate cancer risk. Instead, day-to-day habits like diet, exercise, and regular checkups still play a bigger role in staying healthy. keep reading

Curcumin, found in turmeric, is drawing scientific attention for its effects on prostate cancer, including inhibiting cancer cell growth. Despite promising lab results, making curcumin safe and effective for humans remains a challenge due to poor bioavailability. keep reading

Researchers are questioning if PSMA-PET scans, usually reserved for advanced prostate cancer, might offer added value when used alongside mpMRI earlier in diagnosis. Studies suggest a combined approach could improve detection, but questions remain about cost, accuracy, and future role. keep reading

What happens when prostate cancer questions collide with AI chatbots, social media, and the limits of technology? While online tools can supply fast answers, they can’t replicate the nuanced understanding between patient and physician. New research suggests online information should supplement, not replace, medical expertise. keep reading